Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
551 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00334802 | Combination Chemotherapy of Gemcitabine and Paclitaxel for Metastatic Breast Cancer | completed | Phase 2 | 62 | Eli Lilly and CompanyINDUSTRY | 1 | Mar 16, 2010 | clinicaltrials |
| NCT00191854 | Gemcitabine Combinations in Metastatic Breast Cancer (MBC), 1st Line | completed | Phase 2 | 147 | Eli Lilly and CompanyINDUSTRY | 6 | Mar 2, 2010 | clinicaltrials |
| Gemcitabine or Gemcitabine Plus Docetaxel After Cisplatin, Etoposide and Radiation in Non Small Cell Lung Cancer (NSCLC) |
| completed |
| Phase 2 |
| 64 |
| Eli Lilly and CompanyINDUSTRY |
| 4 |
| Feb 17, 2010 |
| clinicaltrials |
| NCT00402051 | Chemotherapy With Pemetrexed in Combination With Platinum for Advanced Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 133 | Eli Lilly and CompanyINDUSTRY | 1 | Feb 17, 2010 | clinicaltrials |
| NCT00191152 | A Phase III Trial For Patients With Metastatic Breast Cancer | completed | Phase 3 | 475 | Eli Lilly and CompanyINDUSTRY | 8 | Dec 24, 2009 | clinicaltrials |
| NCT00191191 | To Investigate Efficacy and Safety of Pemetrexed as Second or Third Line Therapy in Patients With Non-small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 226 | Eli Lilly and CompanyINDUSTRY | 1 | Dec 9, 2009 | clinicaltrials |
| NCT00461786 | A Study of Single Agent Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer | completed | Phase 2 | 51 | Eli Lilly and CompanyINDUSTRY | 1 | Dec 4, 2009 | clinicaltrials |
| NCT00190671 | A Study of Pemetrexed and Cyclophosphamide Given Every 21 Days in Advanced Breast Cancer Patients | completed | Phase 1 / Phase 2 | 103 | Eli Lilly and CompanyINDUSTRY | 6 | Nov 20, 2009 | clinicaltrials |
| NCT00190983 | A Trial for Patients With Advanced/Recurrent Cervical Cancer | completed | Phase 2 | 29 | Eli Lilly and CompanyINDUSTRY | 1 | Nov 20, 2009 | clinicaltrials |
| NCT00191451 | A Study of Gemcitabine and Carboplatin (Plus Herceptin in Human Epidermal Growth Factor Receptor 2 Positive [HER2+] Patients) With Metastatic Breast Cancer | completed | Phase 2 | 150 | Eli Lilly and CompanyINDUSTRY | 1 | Nov 20, 2009 | clinicaltrials |
| NCT00377520 | A Trial for Patients With Advanced/Recurrent Endometrial Cancer | completed | Phase 2 | 27 | Eli Lilly and CompanyINDUSTRY | 1 | Nov 20, 2009 | clinicaltrials |
| NCT00380588 | Randomized Phase 2 Study With Gemcitabine Alone and Combination Therapy for Patients With Advanced Biliary Tract Cancer | completed | Phase 2 | 84 | Eli Lilly and CompanyINDUSTRY | 1 | Nov 20, 2009 | clinicaltrials |
| NCT00494026 | Chemotherapy and Radiotherapy to Treat Patients With Limited Stage of Small Cell Lung Cancer (SCLC) | terminated | Phase 2 | 4 | Eli Lilly and CompanyINDUSTRY | 4 | Nov 20, 2009 | clinicaltrials |
| NCT00191815 | Combination Chemotherapy for Metastatic Breast Cancer | completed | Phase 2 | 70 | Eli Lilly and CompanyINDUSTRY | 2 | Nov 11, 2009 | clinicaltrials |
| NCT00191477 | Instillation of Gemcitabine in Patients With Superficial Bladder Cancer | terminated | Phase 3 | 355 | Eli Lilly and CompanyINDUSTRY | 1 | Oct 28, 2009 | clinicaltrials |
| NCT00363415 | Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung Cancer | completed | Phase 3 | 908 | Eli Lilly and CompanyINDUSTRY | 26 | Oct 28, 2009 | clinicaltrials |
| NCT00447421 | A Study to Treat Small Cell Lung Cancer With a Combination of Cisplatin, Pemetrexed, and Radiotherapy | terminated | Phase 1 / Phase 2 | 9 | Eli Lilly and CompanyINDUSTRY | 2 | Oct 28, 2009 | clinicaltrials |
| NCT00370292 | Dosage Schedule Study of Pemetrexed Monochemotherapy for Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 19 | Eli Lilly and CompanyINDUSTRY | 1 | Oct 20, 2009 | clinicaltrials |
| NCT00320515 | Study of Pemetrexed Plus Cisplatin in Advanced Gastric Cancer | completed | Phase 1 / Phase 2 | 89 | Eli Lilly and CompanyINDUSTRY | 4 | Sep 28, 2009 | clinicaltrials |
| NCT00191100 | Comparative Study of Gemcitabine,Cisplatin and Radiation Versus Cisplatin and Radiation in Cancer of the Cervix | completed | Phase 3 | 515 | Eli Lilly and CompanyINDUSTRY | 7 | Aug 11, 2009 | clinicaltrials |
| NCT00330915 | A Study of Pemetrexed and Folic Acid Given Before Surgery (Neoadjuvant Treatment) to Patients With Rectal Cancer. | completed | Phase 2 | 37 | Eli Lilly and CompanyINDUSTRY | 1 | Jul 21, 2009 | clinicaltrials |
| NCT00316199 | Efficacy Study of Gemcitabine-Paclitaxel to Treat Metastatic Breast Cancer | completed | Phase 2 | 60 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 17, 2009 | clinicaltrials |
| NCT00383331 | Pemetrexed and Gemcitabine Every 14 Days Versus Every 21 Days in Advanced Non Small Cell Lung Cancer | terminated | Phase 2 | 19 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 3, 2009 | clinicaltrials |
| NCT00259285 | Pemetrexed and Cisplatin Treatment Before Surgery in Non Small Cell Lung Cancer | terminated | Phase 2 | 10 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 2, 2009 | clinicaltrials |
| NCT00106002 | Pemetrexed as the First Treatment in Advanced or Metastatic Breast Cancer | completed | Phase 2 | 37 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 1, 2009 | clinicaltrials |
| NCT00063570 | Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane Therapy | completed | Phase 2 | 73 | Eli Lilly and CompanyINDUSTRY | 2 | May 29, 2009 | clinicaltrials |
| NCT00475657 | Pemetrexed and Cisplatin as Treatment in Small Cell Lung Cancer | terminated | Phase 2 | 5 | Eli Lilly and CompanyINDUSTRY | 1 | May 29, 2009 | clinicaltrials |
| NCT00087698 | Phase II Trial of Neo-Adjuvant Pemetrexed Plus Cisplatin Followed by Surgery and Radiation for Pleural Mesothelioma | completed | Phase 2 | 77 | Eli Lilly and CompanyINDUSTRY | 1 | May 12, 2009 | clinicaltrials |
| NCT00191334 | Gemcitabine in Ovarian Cancer | completed | Phase 2 | 50 | Eli Lilly and CompanyINDUSTRY | 1 | Mar 27, 2009 | clinicaltrials |
| NCT00452257 | A Study of Enzastaurin in Patients With Leukemia | completed | Phase 1 | 18 | Eli Lilly and CompanyINDUSTRY | 1 | Mar 19, 2009 | clinicaltrials |
| NCT00415155 | A Study of LY2181308 in Patients With Advanced Hepatocellular Carcinoma | withdrawn | Phase 1 / Phase 2 | 60 | Eli Lilly and CompanyINDUSTRY | 4 | Aug 29, 2008 | clinicaltrials |
| NCT00386087 | Enzastaurin For Breast Cancer Patients Who Previously Received an Anthracycline and a Taxane Chemotherapy | completed | Phase 2 | 41 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 6, 2008 | clinicaltrials |
| NCT00069875 | A Study With Gemcitabine, Cisplatin, and LY293111 in Non-Small Cell Lung Cancer | completed | Phase 2 | 195 | Eli Lilly and CompanyINDUSTRY | 6 | Dec 21, 2007 | clinicaltrials |
| NCT00067730 | A Safety Evaluation of Drotrecogin Alfa (Activated) in Patients With Blood Cancer, Severe Infection Related to Bone Marrow Transplantation | completed | Phase 4 | 7 | Eli Lilly and CompanyINDUSTRY | 1 | Dec 7, 2007 | clinicaltrials |
| NCT00102219 | A Study of Pemetrexed Plus Doxorubicin Given to Patients With Advanced Breast Cancer | completed | Phase 2 | 77 | Eli Lilly and CompanyINDUSTRY | 7 | Nov 30, 2007 | clinicaltrials |
| NCT00191412 | A Study of Pemetrexed in the Treatment of Patients With Advanced Metastatic Cancer of the Liver | completed | Phase 2 | 41 | Eli Lilly and CompanyINDUSTRY | 1 | Nov 20, 2007 | clinicaltrials |
| NCT00192101 | Gemcitabine Plus Cisplatin Single Dose Versus Split Dose in the Treatment of Patients With Locally Advanced or Metastatic Breast Cancer After Failure of Anthracyclines and/or Taxanes | completed | Phase 2 | 100 | Eli Lilly and CompanyINDUSTRY | 1 | Nov 20, 2007 | clinicaltrials |
| NCT00190710 | A Trial of Carboplatin and Gemcitabine Versus Gemcitabine Alone in Patients With Non-Small-Cell Lung Cancer | completed | Phase 3 | 242 | Eli Lilly and CompanyINDUSTRY | 1 | Nov 14, 2007 | clinicaltrials |
| NCT00079872 | Pemetrexed Plus a Comparator Versus a Combination of 2 Comparators in First-Line Treatment of Colorectal Cancer | completed | Phase 2 | 120 | Eli Lilly and CompanyINDUSTRY | 5 | Nov 6, 2007 | clinicaltrials |
| NCT00191763 | Neo-Adjuvant Gemcitabine and Cisplatin in Treating Patients With Early Stage of Non Small Cell Lung Cancer | completed | Phase 2 | 52 | Eli Lilly and CompanyINDUSTRY | 1 | Nov 6, 2007 | clinicaltrials |
| NCT00191971 | 2nd Line Gemcitabine Monotherapy for Transitional Cell Carcinoma of Urothelium (TCC) After CDDP Regimen | completed | Phase 2 | 40 | Eli Lilly and CompanyINDUSTRY | 1 | Nov 6, 2007 | clinicaltrials |
| NCT00251550 | Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma | completed | Phase 1 / Phase 2 | 12 | Eli Lilly and CompanyINDUSTRY | 1 | Nov 6, 2007 | clinicaltrials |
| NCT00191568 | Gemcitabine, Oxaliplatin and Radiotherapy in Treating Patients With Completely Resected Pancreatic Cancer | completed | Phase 2 | 45 | Eli Lilly and CompanyINDUSTRY | 1 | Oct 19, 2007 | clinicaltrials |
| NCT00191373 | A Trial for HER2 Positive Breast Cancer Patients With Metastatic Disease | completed | Phase 2 | 66 | Eli Lilly and CompanyINDUSTRY | 1 | Sep 12, 2007 | clinicaltrials |
| NCT00192062 | A Trial of Gemcitabine Combined With Vinorelbine as First Line Chemotherapy for Metastatic Breast Cancer | completed | Phase 2 | 80 | Eli Lilly and CompanyINDUSTRY | 1 | Aug 31, 2007 | clinicaltrials |
| NCT00190918 | A Trial for Patients With Gestational Trophoblastic Disease | completed | Phase 2 | 50 | Eli Lilly and CompanyINDUSTRY | 1 | Aug 9, 2007 | clinicaltrials |
| NCT00490659 | Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (With Weekly Low Dose Gemcitabine) in Patients With Lung Cancer With Positive Nodes | completed | Phase 2 | 13 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 25, 2007 | clinicaltrials |
| NCT00490711 | Treatment of Paclitaxel Plus Carboplatin Followed by Gemcitabine Plus Carboplatin for Patients With Epithelial Ovarian Cancer | completed | Phase 2 | 7 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 25, 2007 | clinicaltrials |
| NCT00490880 | Neoadjuvant Chemo (Gemcitabine and Cisplatin) With Radical Cystectomy or Radiotherapy in Patients With Bladder Cancer | completed | Phase 2 | 2 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 25, 2007 | clinicaltrials |
| NCT00491114 | Intravesical Chemotherapy Treatment of Superficial Bladder Cancer | completed | Phase 2 | 8 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 25, 2007 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials